Trends in Disease Burden in Germany Results, Implications and Limitations of the Global Burden of Disease Study

Plaß D, Vos T, Hornberg C, Scheidt-Nave C, Zeeb H, Krämer A (2014)
DEUTSCHES ARZTEBLATT INTERNATIONAL 111(38): 629-U18.

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ;
Abstract
Background: The Global Burden of Disease (GBD) study is designed to give a comprehensive and standardized assessment of the health of populations around the world. It measures the burden of disease by considering years of life lost due to premature death as well as years lived with disability. The findings enable the identification of secular trends and disparities between countries and can serve as a basis for decision-making in health policy. Methods: In cooperation with the authors of the GBD study, we summarize the key methods used to assess the burden of disease in terms of disability-adjusted life years (DALYs). We present findings that specifically pertain to Germany, drawn from freely available data of the most recent round of analysis for the years 1990 and 2010. Results: According to the GBD study, life expectancy in Germany rose from 75.4 years in 1990 to 80.2 years in 2010. Ischemic heart disease and back pain caused the largest number of DALYs lost (2.5 million and 2.1 million, respectively). Over the period of the study, the absolute number of DALYs due to ischemic heart disease dropped by 33%, while the number of DALYs due to low back pain rose by 11%. Nutrition-related risks ranked first among all risk factors considered, accounting for 13.8% of total DALYs, followed by high blood pressure and high body-mass index, accounting for 10.9% each. Conclusion: In Germany, important changes have been seen over time in the burden of disease attributable to different chronic diseases. Some of these changes reflect the successful interventions of the past, while others indicate a need for new action. The data from Germany that went into the GBD study must be systematically assessed and supplemented by further data relating to questions of specific relevance in this country.
Publishing Year
ISSN
PUB-ID

Cite this

Plaß D, Vos T, Hornberg C, Scheidt-Nave C, Zeeb H, Krämer A. Trends in Disease Burden in Germany Results, Implications and Limitations of the Global Burden of Disease Study. DEUTSCHES ARZTEBLATT INTERNATIONAL. 2014;111(38):629-U18.
Plaß, D., Vos, T., Hornberg, C., Scheidt-Nave, C., Zeeb, H., & Krämer, A. (2014). Trends in Disease Burden in Germany Results, Implications and Limitations of the Global Burden of Disease Study. DEUTSCHES ARZTEBLATT INTERNATIONAL, 111(38), 629-U18.
Plaß, D., Vos, T., Hornberg, C., Scheidt-Nave, C., Zeeb, H., and Krämer, A. (2014). Trends in Disease Burden in Germany Results, Implications and Limitations of the Global Burden of Disease Study. DEUTSCHES ARZTEBLATT INTERNATIONAL 111, 629-U18.
Plaß, D., et al., 2014. Trends in Disease Burden in Germany Results, Implications and Limitations of the Global Burden of Disease Study. DEUTSCHES ARZTEBLATT INTERNATIONAL, 111(38), p 629-U18.
D. Plaß, et al., “Trends in Disease Burden in Germany Results, Implications and Limitations of the Global Burden of Disease Study”, DEUTSCHES ARZTEBLATT INTERNATIONAL, vol. 111, 2014, pp. 629-U18.
Plaß, D., Vos, T., Hornberg, C., Scheidt-Nave, C., Zeeb, H., Krämer, A.: Trends in Disease Burden in Germany Results, Implications and Limitations of the Global Burden of Disease Study. DEUTSCHES ARZTEBLATT INTERNATIONAL. 111, 629-U18 (2014).
Plaß, Dietrich, Vos, Theo, Hornberg, Claudia, Scheidt-Nave, Christa, Zeeb, Hajo, and Krämer, Alexander. “Trends in Disease Burden in Germany Results, Implications and Limitations of the Global Burden of Disease Study”. DEUTSCHES ARZTEBLATT INTERNATIONAL 111.38 (2014): 629-U18.
This data publication is cited in the following publications:
This publication cites the following data publications:

5 Citations in Europe PMC

Data provided by Europe PubMed Central.

[Musculoskeletal pain].
Casser HR, Schaible HG., Schmerz 29(5), 2015
PMID: 26351130
In reply.
Plass D., Dtsch Arztebl Int 112(12), 2015
PMID: 25838028
Global burden of disease study is of oncological interest.
Wenderlein MJ., Dtsch Arztebl Int 112(12), 2015
PMID: 25838027
Years of life lost.
Brinks R, Hoyer A, Tamayo T, Kowall B, Rathmann W., Dtsch Arztebl Int 112(12), 2015
PMID: 25838026
The disease burden on our shoulders.
Berger K., Dtsch Arztebl Int 111(38), 2014
PMID: 25316517

40 References

Data provided by Europe PubMed Central.

Health expectancies: an overview and critical appraisal
Mathers CD., 2002
Global Burden of Disease (GBD) Visualizations
AUTHOR UNKNOWN, 0
Global Health Data Exchange (GHDx)
AUTHOR UNKNOWN, 0
Global Burden of Disease Study 2010 Healthy Life Expectancy by Country 1990-2010 (updated 2/23/13)
AUTHOR UNKNOWN, 0
GBD Arrow diagram
AUTHOR UNKNOWN, 0
GBD Compare
AUTHOR UNKNOWN, 0
GBD Heatmap
AUTHOR UNKNOWN, 0
Rückenschmerzen
Raspe H., 2012
Todesursachen in Deutschland 2010
AUTHOR UNKNOWN, 2011
Mass gatherings health--creating a public health legacy.
AUTHOR UNKNOWN, Lancet 380(9836), 2012
PMID: 22770441
A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II
Matthews FE, Arthur A, Barnes LE., 0
The global prevalence of dementia: a systematic review and metaanalysis.
Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP., Alzheimers Dement 9(1), 2013
PMID: 23305823
Disability weights for vision disorders in Global Burden of Disease study.
Taylor HR, Jonas JB, Keeffe J, Leasher J, Naidoo K, Pesudovs K, Resnikoff S., Lancet 381(9860), 2013
PMID: 23266227
Age standradization of rates: A new WHO standard
Ahmad OB, Boschi-pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M., 2001

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 25316518
PubMed | Europe PMC

Search this title in

Google Scholar